Age: 76.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Gait disturbance, Grip strength decreased, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: Prescription drug used without a prescription. This case was reported by a consumer via call center representative and described the occurrence of hand swelling n a 76-year-old male patient who received SHINGRIX. On 23rd April 2018, the patient received the 1st dose of SHINGRIX. On 23rd April 2018, less than an hour after receiving SHINGRIX, the patient experience hand swelling, pain in hand, joint pain, neck pain, shoulder pain and prescription drug used without a prescription. On an unknown date, the patient experienced gait stumbling and activities of daily living impaired. The patient was treated with ALEVE. On an unknown date, the outcome of the hand swelling, pain in hand, joint pain, neck pain, shoulder pain, gait stumbling and activities of daily living impaired were not recovered/not resolved and the outcome of the prescription drug used without a prescription was unknown. The reporter considered the hand swelling, pain in hand, joint pain, neck pain, shoulder pain, gait stumbling and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The reporter was the patient. The patient went to his pharmacy and asked for the vaccine without a prescription which led to prescription drug used without a prescription. The patient received SHINGRIX in the left shoulder with no further dosing details. Within about 15 minutes of the injection, the patient's hands and fingers swelled and were extremely painful. Later on the same day of vaccination (less than a day), pain as well started at the same time all at once in different locations described as the wrists, the elbows, both inside and outside of the shoulders, the back of his neck on the lower left side, the hips, the inside and outside of the knees. The symptoms had not changed or resolved. Less that a month after vaccination, the patient experienced stumbling while walking and difficulty getting out of bed. The patient went to the emergency room three days ago on Friday (4th May 2018) due to the symptoms. The patient currently could not open a bottle of ketchup and had not been able to use his fingernails to open a can of Pepsi or close his fingers due to the extreme pain. The emergency room doctor wanted him to be admitted overnight on Friday, 4th May 2018. Because he forgot his phone and lived alone and could not notify anyone he was at the emergency room, he declined to be admitted. The patient was not given any treatment for the symptoms while there. The physical therapist told him at the emergency room that he was stumbling while walking with his left leg occasionally locking up and turning to the right with his have to drag it just a short distance. He got a walker, and the walker did help that symptom. He was having difficulty getting out of bed in that it takes 5 to 10 minutes to get out of bed and rolling out of a chair takes 5 minutes. He was currently taking 16 OTC ALEVE daily for the extreme pain. The patient was referred to his prescribing healthcare professional and pharmacist to discuss reported symptoms and the amount of OTC ALEVE which had been recently taking. He did not know the milligrams strength of ALEVE which he had been taking and was referred to the bottle in order to look for the contact phone number to the other brand manufacture for dosing discussion as well. The reporter gave permission to contact the physician. The reporter could not provide address details of the pharmacy. The reporter thought that his pharmacist already contacted GlaxoSmithKline sometime last week to report his reaction to the SHINGRIX vaccine.